Lapatinib 231277-92-2 Raw Materials Antineoplastic 99%

____________________________________________________________________________________

Lapatinib

Synonyms: lapatinib; n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine; 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-; Lapatinib(TINIBS); N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine; Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine; N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine; 4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline

CAS: 231277-92-2

MF: C29H26ClFN4O4S

MW: 581.0575432

Purity: 99%

Appearance: white crystalline

Product Categories: Molecular Targeted Antineoplastic; anti-neoplastic; Pharmaceutical intermediate; APIs; API; Lapatinib; Anti-cancer& immunity; Inhibitors

____________________________________________________________________________________

Product description

Lapatinib is a breast cancer targeted therapy drug . Breast cancer molecular targeted therapy aims at the occurrence and development of cancer-related genes and their expression products of breast cancer for treatment. Molecular targeted drugs by blocking signal transduction of tumor cells or associated cells , control changes in cell gene expression, in order to inhibit or kill tumor cells.

Lapatinib is a novel targeted anti-cancer drug. It Can act on Her-1 and Her-2 two targets at he same time, the biological effect of the inhibition of tumor cell proliferation and growth arising from this mode of action is much larger than acting on just one target. The so-called targeted therapy, refers to certain receptors, genes or proteins as a key target, and then targets to kill tumor cells related to drugs.

____________________________________________________________________________________

Hot selling pharmaceutical raw materials

Clarithromycin CAS: 81103-11-9
PF-2341066/Crizotinib CAS: 877399-52-5
Rapamycin CAS: 53123-88-9
Trilostane CAS: 13647-35-3
Tacrolimus CAS: 104987-11-3
Ketoconazole CAS: 65277-42-1
Levamisole hydrochloride CAS: 16595-80-5
Daunorubicin hydrochloride CAS: 23541-50-6
Folic acid CAS: 59-30-3
Itraconazole CAS: 84625-61-6
Everolimus CAS: 159351-69-6
Zoledronic acid CAS: 118072-93-8
Aminoglutethimide (Cytadren) CAS: 125-84-8
Rasagiline mesylate CAS: 161735-79-1
Clopidogrel hydrogen sulfate CAS: 135046-48-9
Doxepin hydrochloride CAS: 1229-29-4
Naphazoline hydrochloride CAS: 550-99-2
TELMISARTAN CAS: 144701-48-4
Pramipexole CAS: 104632-26-0
Furazabol CAS: 1239-29-8
Triamcinolone acetonide CAS: 76-25-5
Etilefrine hydrochloride CAS: 943-17-9
Promethazine hydrochloride CAS: 58-33-3
O-PHOSPHORYLETHANOLAMINE CAS: 1071-23-4
Cilastatin CAS : 82009-34-5
Lovastatin CAS: 75330-75-5